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Abstract  
Background: Type II Diabetes Mellitus is a significant and growing health problem worldwide. In Ethiopia, a limited 
number of studies have tried to investigate treatment non adherence and associated factors among type II Diabetes 
Mellitus patients. Therefore, this study was aimed to determine the magnitude of medication non-adherence and its 
associated factors among type II Diabetes Mellitus patients in Adama hospital medical college, central Ethiopia.    
Methods: A facility based cross-sectional study was conducted among 140 Type II Diabetes Mellitus patients in 
Adama Hospital Medical College, central Ethiopia. We used consecutive sampling method, in which every subject 
meeting the criteria of inclusion is selected until the required sample size is achieved. A standardized Patient Health 
Questionnaire (PHQ-9) and Morisky Medication Adherence Scale-8 (MMAS-8) were used to identify the major de-
pressive disorder and medication non adherence, respectively. Data were entered into a computer using EpiData 3.1 
then exported to SPSS software version 20 for analysis. Logistic regression analysis was used to identify factors 
associated with medication non-adherence.    
Results: The magnitude of type II Diabetes Mellitus drug non-adherence was 58.6% (95% CI: 54.7, 62.4). Individuals 
having major depressive disorders (AOR=2.3; 95% CI: 1.1, 5.8), experiencing one or more complications (AOR= 3.3; 
95% CI: 1.9, 9.0), and average income greater than 1000 birr (AOR= 0.4; 95% CI: 0.1, 0.9) were found to be 
independent predictors of medication non-adherence. 
Conclusion: In this study, the magnitude of medication non-adherence was relatively high among type II Diabetes 
Mellitus patients. Therefore, health professionals should early screen for diabetes associated complications and comor-
bid major depressive disorder and treat them early in order to enhance Type II Diabetes Mellitus  patients’ medication 
adherence.  
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Introduction  
Type II Diabetes Mellitus (DM) became a very com-
mon and serious health problem worldwide. In Sub-
Saharan Africa, its magnitude  is highly increasing 
(Hall et al., 2011). It is commonly associated with di-
etary changes, rapid cultural and social changes, in-
creasing urbanization, reduced physical activity, age-
ing populations and other unhealthy behaviors (Kasper 
et al., 2018).  
Among patients with chronic illnesses like Diabetes 
Mellitus, cancer, HIV/AIDS, and cardiovascular dis-
ease, medication non adherence has been recognized 
to be a major problem (Hall et al., 2011). 
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Studies in India and the United States showed that ad-
herence to diabetes medication ranges from 23 to 77% 
(McCabe, 2003; Shobhana et al., 1999). Previous stud-
ies revealed different factors associated with type II 
DM medication non-adherence. Socio-demographic 
variables like (advanced age, gender, educational sta-
tus, and low monthly income) (Africa, 2006, Gimenes 
et al., 2009, Kalyango et al., 2008); preexisting diabe-
tes complications (Tiv et al., 2012), and depression 
(Goldman et al., 2004) were some of the reported as-
sociated factors of medication non adherence among 
type II DM patients.  
In Ethiopia, despite the presence of medication treat-
ments for diabetes mellitus, there is still a very large 
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number of diabetic patients die every year. Medication 
non adherence was the main underlined cause and re-
mains a challenge for the medical professions (Gebre, 
2013). 
In Ethiopia, diabetes care is given at general outpatient 
clinics or hospitals and the Ethiopian Diabetes Asso-
ciation has tried to share its part in diabetes care, pre-
vention, and treatment (Gebre, 2013). Despite the fact 
that diabetic care is given as an outpatient service in 
Ethiopia, adhering to their medication is still difficult 
in type II diabetic patients. Even though there are few 
available studies in Ethiopia about medication non ad-
herence, still the coverage is not enough. Little is also 
known about the adherence status and associated fac-
tors in the study area. Therefore, this study was aimed 
to determine the magnitude of medication non-adher-
ence and its associated factors among Type II Diabetes 
Mellitus patients in Adama Hospital Medical College, 
central Ethiopia. 
Materials and Methods 
Study setting and design 
A facility-based cross-sectional study design was em-
ployed among type II DM patients who have had fol-
low up care at the diabetes clinic at Adama Hospital 
Medical College, in East Showa, Oromia Regional 
State, Ethiopia, from September to October, 2016. 
Adama is located 99 km to southeast of Addis Ababa, 
the capital city of Ethiopia. The Adama Hospital Med-
ical College was established in 1946 G.C. by Italian 
missionaries and was formerly called the Haile Ma-
riam Mammo Memorial Hospital (Habtamu et al., 
2014).  It teaches new innovative medicine, specialty 
in obstetrics and gynecology, general surgery, pediat-
rics, internal medicine, emergency surgery, and anes-
thesia. This hospital is proving services to about 5 mil-
lion people in the east and southern parts of Oromia, 
Afar, Somali region, and Southern Nation, Nationali-
ties and Peoples’ Region (SNNP) (Habtamu et al., 
2014). During study period, according to the data ob-
tained from hospital administer, the hospital has an av-
erage of 199 type II DM patients attending the diabetes 
clinic on a monthly basis for follow-up. 
Population  
All recorded individuals who fulfilled the following 
inclusion criteria: being diagnosed with type II DM 
and at least 18 years old and who were taking diabetes 
medication for the past 6 months and engaged in reg-
ular follow up at Adama Hospital Medical College, di-
abetes clinic, were considered as study population.  
Sample size determination and sampling technique 
The sample size was calculated using single popula-
tion proportion formula taking the proportion of non-
adherence to type II DM from a previous study in Ja-
maica (0.34) (Swaby et al., 2001) with a marginal error 
of 5% and a 95% confidence level. Since at our study 
facility, the total number of type II DM patients ex-
pected to attend the diabetes clinic each month was 
less than 10,000, we used the finite population correc-
tion formula to calculate the final sample size. Finally, 
by adding a 10% non-response rate, the final sample 
size was determined to be 140. We used consecutive 
sampling method in which every subject meeting the 
criteria of inclusion is selected until the required sam-
ple size is achieved. 
Data collection instrument and technique  
Data were collected using an adapted structured ques-
tionnaire and reviewing patients’ record. The ques-
tionnaire comprised of patients’ socio-demographic 
characteristics, clinical related factors and medication 
adherence rating scale. We used a PHQ-9 standardized 
questionnaire with cut point 10 to identify the major 
depressive disorders. A PHQ-9 threshold score of 10 
was validated to diagnose major depressive disorders 
in eastern Africa and also among Ethiopian adults 
(sensitivity= 86% and specificity=67%) (Gelaye et al., 
2013, Arroll et al., 2010). We used the standardized 
MMAS-8 with cut point 5 for drug non-adherence 
since it has been validated and used in previous Ethio-
pian studies (Abate, 2019). The questionnaire initially 
prepared in English, then translated into local lan-
guages (Afan Oromo and Amharic); further it was re-
translated back to English to maintain its consistency. 
The data were collected by face-to-face interviews and 
some data like glycemic control and experiencing one 
or more complications were collected by reviewing 
patients’ record.  
Data quality control 
Before beginning data collection, the questionnaire 
was pre-tested on 5% of the total sample size to assess 
the feasibility of the questionnaires. The pre-test was 
conducted at Zewditu Memorial Hospital in Addis 
Ababa, Ethiopia. The standardized and widely utilized 
MMAS-8 and a validated PHQ-9 for depression 
screening and diagnosis were used in our study. Inter-
viewers and supervisors were trained and properly 
instructed prior to conducting the survey. The 
collected data were checked for completeness and 
consistency before data entry. 
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Data analysis  
To check the association between medication non-ad-
herence and independent variables, we employed a lo-
gistic regression analysis. Characteristics of the study 
population were described by descriptive statistics.  
Odds ratio with a 95% confidence interval was calcu-
lated to assess the magnitude of association and statis-
tical significance. Those variables with a p-value 
≤0.25 in the bivariate analysis were entered in to mul-
tivariable logistic regression analysis to control for po-
tential confounders and to calculate adjusted odds ra-
tios. Finally, variables with a p-value <0.05 in the mul-
tivariable logistic regression were considered as sig-
nificantly associated with medication non adherence. 
Operational definitions  
Major depressive disorder: A patient is considered as 
having a major depressive disorder if he/she answers 
≥10 points in the PHQ-9 standardized questionnaire 
(Arroll et al., 2010). 
Medication non adherence: A patient is considered as 
medication non adherent if he/she answers <5 points 
on the MMAS-8 (Culig and Leppée, 2014).  
Good glycemic control: Good glycemic control is con-
sidered as type II DM patients’ fasting blood sugar 
control ≤140 mg/dL in the last two months. 
Poor glycemic control: Poor glycemic control is con-
sidered as type II DM patients’ fasting blood sugar 
control >141 mg/dL in the last two months.  
Ethical clearance  
Ethical clearance was obtained from the Institutional 
Research Committee of Adama Hospital Medical Col-
lege. Before data collection, verbal consent was ob-
tained from each participant. All information obtained 
from study participants was treated confidentially. Re-
spondents who were found having major depressive 
disorder in this study were referred to the Adama Hos-
pital Medical College, psychiatry unit for further eval-
uation. 
Results 
Socio-demographic characteristics of the respond-
ents 
A total of 140 type II DM patients who have been tak-
ing diabetes medication in the last 6 months and have 
been engaged in regular follow up were included in 
this study. Of the participants, 51.8% were male, 






income of 500-1000 ETB. The mean (SD) age of par-
ticipants was 46.5 (±9.45) ranging from 18 to 75 years 
(Table 1). 
Table 1: Socio-demographic characteristics of type II 
DM patients on follow up visits at Adama hospital 
medical college, central Ethiopia, 2016. 
Characteristics  Frequency (N) Percent (%) 
Sex  
Male  73 51.8 
Female  67 48.2 
Marital status  
Married  69 48.9 
Single  36 25.5 
Widowed/divorced  35 25.5 
Educational status  
No formal education 36 26.2 
Primary school 42 29.8 
Secondary school 39 27.7 
College/university 21 14.9 
Average monthly income 
< 500 ETB 48 34.0 
501-1000 ETB 56 39.0 
Above 1000 ETB 36 25.5 
Age  
18-40 16 11.43 
41-59 84 60.0 
> 60 40 28.57 
ETB- Ethiopian Birr 
Clinical characteristics of the respondents 
Out of the total respondents, 24.8% had experienced 
one or more complications (like hypertension, diabetic 
foot ulcer and retinopathy) and 74.3% had a fasting 
blood sugar level of ≤140 mg/dL in the past two 
months. A 37.9% of participants were determined to 
have major depressive disorder (Table 2).  
Table 2: Clinical characteristics of type II DM patients 
on follow up visits at Adama hospital medical college, 
central Ethiopia, 2016. 




Glycemic control (mg/dL) 
≤140 104 74.3 
≥141 36 25.7 
Experiencing complications  
Yes 34 24.8 
No 106 75.2 
Major depressive disorder  
No 87 62.1 
Yes   53 37.9 
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The magnitude of medication non-adherence 
In this study, the magnitude of medication non-adher-
ence among type II DM patients was 58.6% (95% CI: 
54.7, 62.4). 
Factors associated with medication non-adherence 
among type II DM patients 
First, we checked the association of each independent 
variable with anti-diabetic medication non-adherence 
using bivariate analysis. Variables including average 
monthly income, experiencing complications, and ma-
jor depressive disorders were significantly associated 
with anti-diabetic medication non-adherence (Table 
3).  
The final model, multivariable logistic regression 
analysis showed that experiencing one or more com-
plications (like HTN, Diabetic foot ulcer and retinopa-
thy), having monthly income above 1000 birr and hav-
ing major depressive disorder had a statistically 
significant association with non-adherence to the anti-
diabetic medication.  
Patients with major depressive disorders were 2.3 
times more likely to have non-adherence to the anti-
diabetic drug therapy than those with no major depres-
sive disorders (AOR=2.3; 95% CI: 1.1, 5.8). Patients 
who had experienced one or more complications (like 
HTN, Diabetic foot ulcer, Retinopathy) were 3.3 times 
more likely to have non-adherence to anti-diabetic 
medication than who did not experience complications 
(AOR=3.3; 95% CI: 1.9, 9.0). However, patients with 
an average monthly income of above 1000 ETB were 
60% less likely to be non-adherent to anti-diabetic 
medication as compared to those with an average 
monthly income of 500 ETB or less (AOR= 0.4; 95% 
CI: 0.1, 0.9) (Table 3).
Table 3: Factors associated with medication non-adherence among type II DM patients on follow up visits at Adama 
hospital medical college, central Ethiopia, 2016. 
Characteristics  Adherent  Non-adherent  COR (95% CI)  AOR (95% CI) 
Sex  
Male 28 (38.4) 45 (61.6) 1  
Female  29 (43.3) 38 (56.7) 0.82 (0.42, 1.6)  
Marital status  
Married  30 (43.5) 39 (56.5) 1  
Single  13 (36.1) 23 (63.9) 1.36 (0.59, 3.12)   
Widowed/divorced 14 (40) 21 (60) 1.15 (0.5, 2.63)  
Educational status 
Unable to read and write  16 (44.4) 20 (55.6) 1 1 
Primary school 15 (35.7) 27 (64.3) 1.4 (0.57, 3.58) 2.21 (0.81, 5.99) 
Secondary school 20 (51.3) 19 (48.7) 0.76 (0.3, 1.88)  0.73 (0.31, 1.68) 
College/University  6 (28.6) 15 (71.4) 2.0 (0.62, 6.33) 2.62 (0.62, 10.89) 
Age  
18-40 9(56.25) 7(43.75) 1.18 (0.58, 2.36)  
41-59 30(35.71) 54(64.29) 2.70 (1.92, 5.28)  
> 60 18(45.0) 22(55.0) 1  
Average monthly income 
< 500 ETB 16 (33.3) 32 (66.7) 1 1 
501-1000 ETB 21 (37.5) 35 (62.5) 0.83 (0.31, 1.86) 0.83 (0.31, 1.86) 
Above 1000 ETB 20 (55.6) 16 (44.4) 0.4 (0.16, 0.97)*  0.4 (0.16, 0.97)* 
Experiencing complications  
Yes  9 (26.5) 25 (73.5) 0.43 (0.18, 0.99)* 3.3 (1.9, 9.0)* 
No  48 (45.3) 58 (54.7) 1 1 
Glycemic control (mg/dL) 
≤140 40 (38.5) 64 (61.5) 1  
≥140 17 (47.2) 19 (52.8) 0.69 (0.32, 1.5)  
Major depressive disorder  
No 42 (48.3) 45 (51.7) 1 1 
Yes  15 (28.3) 38 (71.7) 2.4 (1.13, 4.9)* 2.3 (1.13, 5.8)* 
ETB - Ethiopian birr       *(statistically significant)     
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Discussion 
This study was designed to determine the magnitude 
of type II DM medication non-adherence and its asso-
ciated factors. The magnitude of anti-diabetic medica-
tion non-adherence was found to be 58.6% (95% CI: 
54.7, 62.4), and factors including major depressive 
disorders, experiencing complications, and average in-
come greater than 1000 birr were significantly associ-
ated with medication non-adherence.  
 
In this study, the magnitude of medication non-adher-
ence was found relatively higher than that of the earlier 
Indian studies (Divya and Nadig, 2015, Shobhana et 
al., 1999) which reported 30% and 50% non-adher-
ence rates respectively. In this study, more than thirty 
percent of the respondents reported major depressive 
disorder, which was found to be associated with med-
ication non-adherence. The other possible justification 
for the higher medication non-adherence in this study 
is, the magnitude of patients who are unable to read 
and write (36%), since the level of education was one 
of the confirmed associated factors for medication 
non-adherence in previous studies. Patients who are 
unable to read and write were more than five times 
more likely to be non-adherent to their medication 
than those who completed grades 1-6 (Abebaw et al., 
2016). 
 
The magnitude of medication non-adherence in this 
study was also lower than the results of some previous 
studies (Grant et al., 2003, Inbaraj et al., 2016, 
Schectman et al., 2002, Abate, 2019), which revealed 
68.8%, 70%, 79.7%, and 95.7% non-adherence rates 
respectively. This could be due to the improved com-
munity awareness on chronic illnesses such as diabe-
tes, the availability of better treatments, and good ther-
apeutic communication between medical profession-
als and patients.  
 
In our study, type II DM patients who had major de-
pressive disorder were more likely to be medication 
non-adherent as compared to patients who had no ma-
jor depressive disorder. This result is in line with pre-
vious studies (Lin et al., 2004, Sweileh et al., 2014, 
Gelder et al., 2004, Kaplan, 2016). Previous study also 
indicates that depression causes poorer diabetes self-
care (Gonzalez et al., 2008). This finding is one of the 
very important indications for interventions to de-
crease the magnitude of medication non-adherence. 
Having early screening and providing appropriate 
treatments for major depressive disorders is  
 
fundamental to enhance treatment adherence among 
patients with type II DM (Gonzalez et al., 2008). 
 
The results of this study indicated that, patients with 
an average monthly income of above 1000 ETB were 
60% less likely to have medication non-adherence as 
compared to those with an average monthly income of 
< 500 ETB. This result is in line with previous studies 
(Gimenes et al., 2009; Schectman et al., 2002).  
 
This study also, found that patients who had experi-
enced one or more complications had higher odds of 
medication non-adherence as compared to who had 
not experienced complications. This result is sup-
ported by a previous study (MuKherjee et al., 2013). 
In this study, about 24.8% of DM patients developed 
one or more complications like Hypertension (HTN), 
Diabetic foot ulcer, Retinopathy in the last two 
months. This complication also need additional man-
agement which can complicates the quality of life of 
DM patients. 
 
Limitations of the study  
The study was conducted using face to face interview 
which could have a social desirability bias and an un-
der-reporting of the magnitude of type II DM medica-
tion non-adherence. This study also used cross-sec-
tional study design which could not identify the cause 
and effect relationships between independent variables 
and medication non-adherence. Additionally, the inde-
pendent factors included in the current study were not 
comprehensive enough.  
 
Conclusion  
The magnitude of medication non-adherence was rel-
atively high among type II DM patients. Factors in-
cluding major depressive disorders, experiencing 
complications, and average income greater than 1000 
birr were significantly associated with medication non 
adherence. Therefore, this study recommends that the 
health professionals who are treating type II DM pa-
tients should early screen DM associated complica-
tions and comorbid major depressive disorder and treat 
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